Regeneron Pharmaceuticals Stock Target Price and Analyst Consensus
REGN Stock | USD 907.32 7.16 0.80% |
The current analyst and expert consensus on Regeneron Pharmaceuticals is Buy with 8 buy recommendations. The current projected Regeneron Pharmaceuticals target price consensus is 912.52, with 28 analyst opinions. The most common way Regeneron Pharmaceuticals analysts use to provide public buy-or-sell recommendation is financial statements analysis. They also talk to Regeneron Pharmaceuticals executives, vendors, and/or customers. Regeneron Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Regeneron Pharmaceuticals target price to derive its highest and lowest estimates based on target price estimated volatility of 0.0. Check out Macroaxis Advice on Regeneron Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.
Lowest Forecast 830.39 | Highest Forecast 1 K | Target Price 912.52 |
Regeneron |
It's important to approach Regeneron Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Regeneron Pharmaceuticals price targets
Regeneron Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Regeneron Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Regeneron Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Regeneron Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Regeneron Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Regeneron Pharmaceuticals is a key component of Regeneron Pharmaceuticals valuation and have some predictive power on the future returns of a Regeneron Pharmaceuticals.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Regeneron Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Blockchain Invested a lot of shares | ||
Chemicals Invested over 40 shares | ||
FinTech Invested over 50 shares | ||
Momentum Invested few shares | ||
Dividend Beast Invested over 70 shares | ||
Driverless Cars Invested over 200 shares | ||
Automobiles and Trucks Invested over 200 shares | ||
Hedge Favorites Invested over 70 shares | ||
Check out Macroaxis Advice on Regeneron Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Regeneron Stock analysis
When running Regeneron Pharmaceuticals' price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
The data published in Regeneron Pharmaceuticals' official financial statements usually reflect Regeneron Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Regeneron Pharmaceuticals. For example, before you start analyzing numbers published by Regeneron accountants, it's critical to develop an understanding of what Regeneron Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Regeneron Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Regeneron Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Regeneron Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Regeneron Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Regeneron Pharmaceuticals' management manipulating its earnings.